CARTER GITLIN: Open Payments
NPI 1770260408 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$511 in 24 payments from 12 companies in 2025. Trend: 2023 $280 · 2024 $457 · 2025 $511
Food & beverage: $511
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 5 | $129 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| Exeltis, USA Inc. | 3 | $53 |
| Evofem Biosciences, Inc. | 3 | $51 |
| Dexcom, Inc. | 2 | $48 |
| PFIZER INC. | 2 | $40 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $26 |
| Organon LLC | 1 | $25 |
| Astellas Pharma US Inc | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: ZURZUVAE, Kyleena, SLYND, Phexxi, Dexcom G6 Transmitter, NEXPLANON, Veozah, COMIRNATY.
Industry payments across NC — which companies pay providers there.
